2Lipton R, Stewart W, Diamond S, et al. Prevalence and burden of migraine in the United States :data from the American Migraine Study[J].Headache,2001,4! (7):646-57.
3Sigrid S, Mandana T, Reuter U, et al. Effects of parecoxib on plasma protein extravasations and c-fos expression in the rat [J]. Headache, 2006; 46(2):276-85.
4Knyiha E, Tajti J, Chadaide Z, et al.Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model [J]. Microsc Res Tech,2001,53(3): 193-211.
5Schwenger N, Dux M, Coil R, et al. Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater [J]. Cephalalgia, 2007, 27(6): 481-91.
6Vanessa K, Moshe J, Rami B, et al. Localization of COX-1 and COX-2 in the intracranial dura mater of the rat[J]. Neuroscience Letters,2009, 452(1):33-6.
7Silberstein S, Goldstein J, Winner P, et al. Randomized, placebo-controlled trial of rofecoxin the acute treatment of migraine [J]. Neurology, 2004, 62:155(9): 1552-7.
8Zimmermann K, Reeh P, Averbeck B. S(+)-flurbiprofen but not 5-HTI agonists suppress basal and stimulated CGRP and PGE2 release from isolated rat dura mater[J]. Pain, 2003,103(3):313-20.
9Shimizu T, Toriumi H, Sato H, et al. Distribution and origin of TRPVI receptor-containing nerve fibers in the dura mater of rat [J]. Brain Res, 2007, 1173:84-91.
10D'Andrea G, Leon A. Pathogenesis of migraine: from neurotransmitters to neuromodulators arid beyond [J]. Neurol Sci. 2010, 31 Suppl 1:S1-7.
